Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aisling Capital is a venture capital firm founded in 2000 and based in New York, NY. The firm has raised over $1.8 billion in committed capital across multiple funds and employs a team with extensive experience in the healthcare industry.
Aisling Capital invests in both private and public companies within the life sciences sector, focusing on seed and venture financing for development-stage companies. Their investment strategy includes structured debt, royalty deals, and large-cap leveraged buyouts of profitable companies. The firm seeks healthcare products, services, and technologies that address unmet medical needs.
Notable companies in Aisling Capital's portfolio include Aclaris Therapeutics, Inc., a specialty pharmaceutical company focused on dermatology; ADMA Biologics, Inc., developing plasma-based biologics for infectious diseases; Aimmune Therapeutics, Inc., focused on treatments for food allergies; Ajax Health, a medical device platform; and Antios Therapeutics, targeting therapies for viral diseases.
Submit your pitch through their website's contact form for consideration.
Aisling Capital often leads investment rounds, particularly in seed and Series A stages, where they can provide significant capital and strategic guidance.
The firm actively participates in follow-on investments to support portfolio companies as they grow and scale, ensuring they have the necessary resources to succeed.
Aisling Capital has a fund size of $1.8 billion, allowing them to make substantial investments across various stages of company development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.